full issue - Association of Biotechnology and Pharmacy
full issue - Association of Biotechnology and Pharmacy
full issue - Association of Biotechnology and Pharmacy
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Current Trends in <strong>Biotechnology</strong> <strong>and</strong> <strong>Pharmacy</strong><br />
Vol. 5 (3) 1309-1317 July 2011, ISSN 0973-8916 (Print), 2230-7303 (Online)<br />
1316<br />
coexpression <strong>of</strong> the L1 <strong>and</strong> L2 capsid<br />
proteins. J. Virol., 67: 315–322<br />
9. Villa LL. (2010). HPV prophylactic<br />
vaccination: The first years <strong>and</strong> what to<br />
expect from now. Cancer letters.<br />
10. Fern<strong>and</strong>ez- San Millan A, Ortogosa SM,<br />
Herras- Stubbs S Corral- Martinez P, Sequi-<br />
Simmaro JM, Gactan J, Coursaget P,<br />
Veramendi J. (2008). Human<br />
papillomavirus L1 protein expressed in<br />
tobacco chloroplasts self- assembles into<br />
virus-like particles that are highly<br />
immunogenic. Plant Biotechnol J. 6(5):<br />
427-41<br />
11. Bimelt S, Sonnewald U, Galmbachar P,<br />
Willmitzer L, Muller M . (2003) Production<br />
<strong>of</strong> human papillomaviruses type 16 viruslike<br />
particles in transgenic plants. J Virol.<br />
77: 9211-9220.<br />
12. Varsani A, Williamson AL, Rose RC, Jaffer<br />
M, Rybicki EP. (2003). Expression <strong>of</strong><br />
human papillomavirus type 16 major capsid<br />
protein in transgenic Nicotiana tabacum cv.<br />
Xanthi. Arch Virol. 148: 1771-1786.<br />
13. Nardelli-Haefliger D, Roden RB,<br />
Benyacoub J, Sahli R, Kraehenbuhl JP,<br />
Schiller JT, Lachat P, Potts A, De Gr<strong>and</strong>i P.<br />
(1997). Human papillomavirus type 16<br />
virus-like particles expressed in attenuated<br />
Salmonella typhimurium elicit mucosal <strong>and</strong><br />
systemic neutralizing antibodies in mice.<br />
Infect Immun. 65(8):3328-36.<br />
14. Zhou J, Sun XY, Stenzel DJ, Frazer IH.<br />
(1991). Expression <strong>of</strong> vaccinia recombinant<br />
HPV 16 L1 <strong>and</strong> L2 ORF proteins in<br />
epithelial cells is sufficient for assembly <strong>of</strong><br />
HPV virion-like particles. Virology.<br />
185(1):251-7<br />
15. Roberts, J.N., Buck, C.B., Thompson, C.D.,<br />
Kines, R. <strong>and</strong> Bernardo, M. (2007). Genital<br />
transmission <strong>of</strong> HPV in a mouse model is<br />
potentiated by nonoxynol-9 <strong>and</strong> inhibited<br />
by carrageenan. Nat. Med. 13(7): 857–861.<br />
16. Holmgren, S.C., Patterson, N.A., Ozbun,<br />
M.A. <strong>and</strong> Lambert, P.F. (2005). The minor<br />
capsid protein L2 contributes to two steps<br />
in the human papillomavirus type 31 life<br />
cycle. J. Virol. 79(7): 3938–3948<br />
17. Gambhira, R., S. Jagu, B. Karanam, P. E.<br />
Gravitt, T. D. Culp, N. D. Christensen. <strong>and</strong><br />
R. B. S. Roden. (2007). Protection <strong>of</strong><br />
rabbits against challenge with rabbit<br />
papillomaviruses by immunization with the<br />
N terminus <strong>of</strong> human papillomavirus type<br />
16 minor capsid antigen L2. J. Virol.<br />
81:11585–11592<br />
18. Embers, M. E., L. R. Budgeon, M. Pickel.<br />
<strong>and</strong> N. D. Christensen. (2002). Protective<br />
immunity to rabbit oral <strong>and</strong> cutaneous<br />
papillomaviruses by immunization with<br />
short peptides <strong>of</strong> L2, the minor capsid<br />
protein. J. Virol. 76:9798–9805<br />
19. Gaukroger, J. M., L. M. Ch<strong>and</strong>rachud, B.<br />
W. O’Neil, G. J. Grindlay, G. Knowles. <strong>and</strong><br />
M. S. Campo.(1996). Vaccination <strong>of</strong> cattle<br />
with bovine papillomavirus type 4 L2<br />
elicits the production <strong>of</strong> virus-neutralizing<br />
antibodies. J. Gen. Virol. 77:1577–1583<br />
20. Kawana, K., Yasugi, T., K<strong>and</strong>a, T., Kino,<br />
N., Oda, K., Okada, S., Kawana, Y., Nei,<br />
T., Takada, T., Toyoshima, S., Tsuchiya, A.,<br />
Kondo, K., Yoshikawa, H., Tsutsumi, O.<br />
<strong>and</strong> Taketani, Y. (2003). Safety <strong>and</strong><br />
immunogenicity <strong>of</strong> a peptide containing the<br />
cross-neutralization epitope <strong>of</strong> HPV16 L2<br />
administered nasally in healthy volunteers.<br />
Vaccine. 21: 4256–4260<br />
Hanumantha Rao et al